Draft European Medicines Agencies Network Data Strategy - Increasing the value of data for the benefit of public and animal health

Human medicines European public assessment report (EPAR): Gohibic, vilobelimab, Status: Opinion

Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Status: Opinion

Human medicines European public assessment report (EPAR): Augtyro, repotrectinib, Status: Opinion

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 November 2024

Human medicines European public assessment report (EPAR): Cinainu, dry aqueous extract of paullinia cupana seed,dry hydroethanolic extract of theobroma cacao seed,liquid ethanolic extract 30 per cent (W/W) of Allium cepa fresh bulb and Citrus limon fresh fruit, Status: Opinion

Summary of opinion: Kevzara, 14/11/2024 Positive

Summary of opinion: Sarclisa, 14/11/2024 Positive

Summary of opinion: Jakavi, 14/11/2024 Positive

Summary of opinion: CellCept, 14/11/2024 Positive